Skip to content

The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers

The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06654362
Enrollment
1097
Registered
2024-10-23
Start date
2023-09-23
Completion date
2024-05-20
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Sugar, Lipid Profile, Weight Change

Keywords

public health, workers, nutrition

Brief summary

The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers. The main questions it aims to answer are: Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid profile factors among workers? Researchers will compare glycemic and lipid profile factors among workers before and after nutritional intervention .

Interventions

BEHAVIORALnutritional interventions include education and modifying company's restaurant menu

* Reducing fried foods and replacing them with healthier alternatives. * Decreasing the consumption of sweetened beverages such as soda and replacing them with yogurt. * Reducing the intake of refined grains and substituting with whole grains. * Increasing fruit intake. * Increasing the intake of vegetables as much as possible. * Organizing face-to-face educational sessions with the chef to train them and improve cooking methods, to reduce fat and oil intake.

Sponsors

Peyman Sarsangi
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* be Arfa's company worker

Exclusion criteria

* individuals who were diagnosed with any type of cancer

Design outcomes

Primary

MeasureTime frame
Total Cholesterol, mg/dLFrom enrollment to the end of intervention at 6 months
Total triglycerides, mg/dLFrom enrollment to the end of intervention at 6 months
Low-density lipoprotein, mg/dLFrom enrollment to the end of intervention at 6 months
High-density lipoprotein, mg/dlFrom enrollment to the end of intervention at 6 months
Fast blood sugar, mg/dLFrom enrollment to the end of intervention at 6 months
serum glutamic oxaloacetic transaminase, IU/LFrom enrollment to the end of intervention at 6 months
serum glutamic pyruvic transaminase, IU/LFrom enrollment to the end of intervention at 6 months

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026